{"id":510,"date":"2010-08-24T20:57:00","date_gmt":"2010-08-25T03:57:00","guid":{"rendered":"http:\/\/depts.washington.edu\/krslab\/"},"modified":"2018-06-04T14:02:01","modified_gmt":"2018-06-04T21:02:01","slug":"members-carly-bridge","status":"publish","type":"page","link":"https:\/\/mathematicalneurooncology.org\/?page_id=510","title":{"rendered":"Members: Carly Bridge"},"content":{"rendered":"<p><img class=\"alignleft\" title=\"Doctor Carly Bridge\" src=\"https:\/\/mathematicalneurooncology.org\/wp-content\/uploads\/2013\/07\/Carly_cropped.jpg\" alt=\"\" width=\"150\" align=\"left\" \/><strong>Carly Bridge, ND<\/strong><br \/>\n<strong> Research Scientist<\/strong><br \/>\n<strong> Mary Gates Research Scholar 2003<\/strong><\/p>\n<p><a href=\"https:\/\/mathematicalneurooncology.org\/wp-content\/uploads\/2013\/07\/Carly-Bridge-CV-basic.docx\">Curriculum Vitae<\/a><\/p>\n<p>Dr. Carly Bridge originally joined the lab in 2001 as Dr. Swanson\u2019s first student researcher. She spent three years working alongside Kristin and Buster in a one room office as she pursued her undergraduate degree in Neurobiology. Following graduation, she chose to attend Bastyr University for her formal medical training and received her Doctorate in Naturopathic Medicine in 2009. She then completed a nationally accredited Family Practice residency affiliated through the Bastyr Center for Natural Health. During her residency she continued pursuing her interests in teaching and research and ultimately felt the calling\u00a0to return\u00a0to academia.<\/p>\n<div><\/div>\n<div><strong>ARTICLES&#8211;PEER REVIEWED:<\/strong><\/div>\n<ul>\n<li>K. R. Swanson, <strong>C. Bridge<\/strong>, J. D. Murray, E. C. Alvord Jr.: Virtual and Real Brain Tumors: Using Mathematical Modeling to Quantify Glioma Growth and Invasion.\u00a0<em>Journal of the Neurological Sciences<\/em>, 216(1):1-10, 2003.\u00a0 <strong>Pubmed ID:\u00a0<\/strong><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/sites\/entrez\/14607296\" target=\"_blank\"><strong>14607296<\/strong><\/a> <a href=\"https:\/\/ec2-107-22-238-17.compute-1.amazonaws.com\/wp-content\/uploads\/2010\/07\/2003-Swanson-et-al-Virtual-and-real-brain-tumors-using-mathematical-modeling-to-quantify-glioma-growth-and-invasion.pdf\" target=\"_blank\"><strong>PDF<\/strong><\/a><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">Standish LJ, Sweet ES, Novack J, Wenner CA, <strong> C. Bridge<\/strong>, Nelson A, Martzen M, Torkelson C.:\u00a0Breast cancer and the immune system. <em>Journal of the Society for Integrative Oncology,<\/em> 6(4):158-68, 2008.\u00a0\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/pmid\/19134448\/?tool=pubmed\" target=\"_blank\"><strong><span style=\"color: #985735;\">Free PMC Article<\/span><\/strong><\/a><\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">Standish LJ, Wenner CA, Sweet ES, <strong>C. Bridge<\/strong>, Nelson A, Martzen M, Novack J, Torkelson C.:Trametes versicolor Mushroom Immune Therapy in Breast Cancer<em>. Journal for the Society for Integrative Oncology<\/em>, 6(3) 122-128, 2008.\u00a0\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19087769\" target=\"_blank\"><strong><span style=\"color: #985735;\">Free PMC Article<\/span><\/strong><\/a><\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">Neal ML, Trister AD, Cloke T, Sodt R, Ahn S, A.Baldock, <strong> C.A. Bridge<\/strong>, et al. Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric. <em>PLoS ONE <\/em>8(1): e51951. doi:10.1371\/journal.pone.0051951<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">M.L. Neal, A.D. Trister, S. Ahn,<strong>C.A. Bridge<\/strong>, L. Guyman, J. Lange, A. Baldock, R. Rockne, M. Mrugala, J.K. Rockhill, A. Lai, T. Cloughesy, K.R. Swanson. Response classification based on a minimal model of glioblastoma growth is a prognostic factor for time to progression and survival. <em>Cancer Research;<\/em> 73(10) 2976-2986, 2013.<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">A. Baldock, R. Rockne, A. Boone, M. Neal, A. Hawkins-Daarud, <strong>C.A. Bridge<\/strong>, L. Guyman, A. D. Trister, M. Mrugala, J. K. Rockhill, K. R. Swanson. From Patient-Specific Mathematical Neuro-Oncology to Precision Medicine.<em> Frontiers in Molecular and Cellular Oncology;<\/em> 3: 62. Published online 2013 April 2. Prepublished online 2013 January 11. doi: 10.3389\/fonc.2013.00062<\/span><\/li>\n<\/ul>\n<div><strong>ABSTRACTS:<\/strong><\/div>\n<ul>\n<li><strong>C. A. Bridge,<\/strong> E. C. Alvord Jr.,\u00a0K. R. Swanson. \u201c Validation of a Mathematical Model for Brain Tumor Growth and Invasion: Serial Followup of an Untreated Glioma\u201d, American Association for the Advancement of Science (Seattle, WA), February 2004<\/li>\n<li>K. R. Swanson, H. Harpold, S. Nissen, <strong>C.A. Bridge,<\/strong> A. Lai, T. Cloughesy, E. C. Alvord, Jr. Monitoring the Effects of Treatment in Glioblastomas: Integrating Mathematical Modeling with Clinical Imaging. Society for Neuro-Oncology (Toronto, Canada), November 2004 -Neuro-Oncology, 6(4):369, 2004<\/li>\n<li>A. Trister, B. Bot, A. Hawkins-Daarud, K. Fontes,<strong> C.A. Bridge,<\/strong> J. K. Rockhill, M. Mrugala, R. Rockne, E. Huang, K. R. Swanson. A novel patient-specific model of glioma growth kinetics elucidates underlying biology as measured by gene expression microarray. Markers in Cancer, October 11-13, 2012 (Hollywood, FL)<\/li>\n<li>M.L. Neal, A.D. Trister, S. Ahn, <strong>C.A. Bridge,<\/strong> J. Lange, A. Baldock, R. Rockne, M. Mrugala, J.K. Rockhill, A. Lai, T. Cloughesy, K.R. Swanson. A response metric based on a minimal model of glioblastoma growth is prognostic for time to progression and overall survival. Society for Neuro-Oncology Annual Meeting, 2012 (Washington, DC).<\/li>\n<li>S.K. Johnston,<strong> C.A. Bridge,<\/strong> R. Rockne, L. Guyman, A. Baldock, J. K. Rockhill, M. Mrugala, S. Adair, H-PP. Kiem, K. R. Swanson. Enabling the Detection of Treatment Benefit in Novel Therapeutic Studies through Patient-Specific Mathematical Modeling: Analysis of Chemoprotective Hematopoietic Stem Cell Gene Therapy in Human Glioblastomas. Annual Meeting of the Society for Neuro-Oncology, 2012 (Washington, DC)<\/li>\n<li>A. Hawkins-Daarud, A. Baldock, <strong>C.A. Bridge,<\/strong> D. Corwin, J. Rockhill, M. Mrugala, R. Rockne, K. R. Swanson. Revealing the diffuse extent of gliomas to enable surgical and radiotherapy treatment design: Insights from a Patient-Specific Mathematical Model and an Untreated Glioblastoma. Annual Meeting of the Society for Neuro-Oncology, 2012 (Washington, DC)<\/li>\n<li>A. Trister, B. Bot, K. Fontes, <strong>C. A. Bridge,<\/strong> J. K. Rockhill, M. Mrugala, R. Rockne, E. Huang, K. R. Swanson. A novel patient-specific model of glioma growth kinetics elucidates underlying biology as measured by gene expression microarray. Annual Meeting of the Society for Neuro-Oncology, 2012 (Washington, DC)<\/li>\n<li><strong>C.A. Bridge,<\/strong> A. Baldock, P. Kumthekar, P. Dilfer, S.K. Johnston, J.Jacobs, D. Corwin, L. Guyman, R. Rockne, A. Sonabend, M. Cloney, P. Canoll, K.R. Swanson \u201cCharacteristics of long-term survivors in glioblastoma\u201d Annual Meeting of the Society for Neuro-Oncology, 2013 (San Francisco, CA)<\/li>\n<\/ul>\n<p>Currently the Medical Science Liason Novocure, Inc<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Carly Bridge, ND Research Scientist Mary Gates Research Scholar 2003 Curriculum Vitae Dr. Carly Bridge originally joined the lab in 2001 as Dr. Swanson\u2019s first student researcher. She spent three years working alongside Kristin and Buster in a one room office as she pursued her undergraduate degree in Neurobiology. Following graduation, she chose to attend &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/mathematicalneurooncology.org\/?page_id=510\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Members: Carly Bridge&#8221;<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":430,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/mathematicalneurooncology.org\/index.php?rest_route=\/wp\/v2\/pages\/510"}],"collection":[{"href":"https:\/\/mathematicalneurooncology.org\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mathematicalneurooncology.org\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mathematicalneurooncology.org\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/mathematicalneurooncology.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=510"}],"version-history":[{"count":10,"href":"https:\/\/mathematicalneurooncology.org\/index.php?rest_route=\/wp\/v2\/pages\/510\/revisions"}],"predecessor-version":[{"id":3344,"href":"https:\/\/mathematicalneurooncology.org\/index.php?rest_route=\/wp\/v2\/pages\/510\/revisions\/3344"}],"up":[{"embeddable":true,"href":"https:\/\/mathematicalneurooncology.org\/index.php?rest_route=\/wp\/v2\/pages\/430"}],"wp:attachment":[{"href":"https:\/\/mathematicalneurooncology.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}